I take this opportunity in inviting all our readers to PSM India’s 2nd International conference at India’s holy city, Haridwar. Please go through our PSM India capsules in this issue to know more on the event.
With the Indian govt. focusing on improving health infrastructure, patient safety seems to be in priority now. Drug laws and pharma injections of this issue gives you an insight into various measures being adopted by the Govt.of India in safeguarding patient safety.
As aware consumers we must contribute our bit too to this cause. We must realize that this is our health that is in question. There is nothing more important than our well-being. The PRESCRIPTION is a small means by which PSM INDIA contributes in making you aware. Hope our articles keep your interest alive in this cause .
If you have any suggestions, comments or queries, please email me at pooja@jagograhakjago.com.
You may find our previous issues on our website jagograhakjago.com or in the NEWS ARCHIVE section of every issue of The PRESCRIPTION, in case you’ve missed any of them. You may also look us up on Facebook under Partnership for Safe Medicines India .
"Call PSM India toll free helpline 1800 - 11- 4424, to bring cases of spurious medicines or any kind of adverse drug reaction to the notice of the authorities.
Please visit our website jagograhakjago.com if you wish to learn about us .
To register a complaint kindly visit our consumer redressal website jagograhakjago.com”
Happy Reading !
Stay Safe. Stay Healthy !
Pooja Khaitan
Chief Editor ,
The PRESCRIPTION
Partnership for Safe Medicines India.
“Pharmacies are the first point of contact for the unwell consumers and pharmacists have a vital role in Indian healthcare which needs to be recognized by the policy makers”.
Mrs. Manjiri Gharat,
Vice-President and Chairperson,
Indian Pharmaceutical Association-Community Pharmacy Division (IPA CPD)
BOOK YOUR TICKETS on http://www.meraevents.com/event/international-conference-psmindiainitiative&ucode=organizer
Join the Partnership for Safe Medicines India movement ! – Campaign against spurious medicines
Watch the video on http://www.youtube.com/watch?v=BDYsYP4uM3M&feature=shareFDA Asks All Medical Professionals to “Know Your Source” To Protect Patients from Fake DrugsSeptember, 2014: The FDA has a new flyer campaign that asks doctors, medical office managers, and others responsible for medication purchasing to ensure that they only buy FDA-approved medication. Only state-licensed wholesale distributors of medication can guarantee the safety of medication prescribed to patients.
FDA Approves Uceris (budesonide) Rectal Foam for Ulcerative Colitis
RALEIGH, N.C., October 2014 : Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Food and Drug Administration (FDA) has granted final approval for Uceris (budesonide) rectal foam for the induction of remission in patients with active mild-to-moderate distal ulcerative colitis (UC) extending up to 40cm from the anal verge. The foam is a rectally administered corticosteroid that overcomes treatment limitations associated with currently approved therapies which are often ineffective due to insufficient distribution of active drug to the distal colon.
Frequently Asked Questions Q1. What are ophthalmic preparations?
Answer: Ophthalmic preparations (eye preparations) are sterile, liquid, semi-solid, or solid preparations that may contain one or more active pharmaceutical ingredient(s) intended for application to the eyes (conjunctiva, the conjunctival sac or the eyelids). The different categories of ophthalmic preparations include drops consisting of emulsions, solutions or suspensions, and ointments. Ophthalmic preparations should maintain their integrity throughout their shelf-life when stored at the temperature indicated on the label. Special storage recommendations or limitations are indicated in individual monographs.
Q2. What are the important instructions that should be remembered while administering such preparations?
Answer: The eye is extremely sensitive and is easily irritated if the composition of the ophthalmic preparation is not appropriate. Eye drops come in single use containers and in multiple dose bottles. Multidose eye drops labelling instruction recommends - To be use within one month (30 days) after opening the container which needs to be followed carefully as they are sterile formulations, but as soon as patients open the bottle for first time, the formulation get exposed to external environment and have high chance of contamination. Moreover, inadvertently dropper tips often touch the eyelids or countertops during use and can contaminate the bottle with bacteria. Preservatives are added to a certain quantity to prevent the solution from external and in inadvertent contamination only up to 30 days. So patient should discard any unused eye drop after 30 days.
Therefore a kind note from PSM Desk that next time you use eye drop/ointment, be careful and diligent in following every instructions as eyes are un-doubted the most vital part of our body.